ABSTRACT Motor impairments in stroke survivors are prevalent and contribute to dependence in daily activities, pain and overall disability, which can further upper-limb disability. Treatment with botulinum toxin A (BoNT-A) is indicated for focal spasticity and requires knowledge of biomechanics and anato...
ABSTRACT Motor and non-motor manifestations are common and disabling features of hereditary spastic paraplegia (HSP). Botulinum toxin type A (Btx-A) is considered effective for spasticity and may improve gait in these patients. Little is known about the effects of Btx-A on non-motor symptoms in HSP patie...
Säo relatados 9 casos de pacientes portadores de lesöes neurológicas diversas que apresentaram, em suas manifestaçöes clínicas, espasticidade grave e/ou espasmos musculares intensos e que foram submetidos a tratamento com o baclofen intrarraquiano. Todos os pacientes foram avaliados longitudinalmen...